Source BioScience is delighted to announce the launch of KRAS and BRAF mutation status testing from our Dublin based laboratory from 8th November 2010. This provision will result in customers based in Ireland receiving a better service and faster turnaround time for these diagnostic tests. This, in turn, will enable clinicians to determine the most appropriate treatment regime and patients to receive more targeted and effective drug therapies. Source BioScience is the first laboratory to offer this service in Ireland and demonstrates our continued commitment to provide high quality diagnostic testing for the Irish healthcare community.
The Company became the first commercial service provider to establish a sequencing laboratory in Ireland with the opening of its Dublin facility in January this year.